ANNEXON, INC. Public Float
ANNEXON, INC. (ANNX) had Public Float of $244.40 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $244.40M.
- 2024-06-28: Entity Public Float $477.20M.
- 2023-06-30: Entity Public Float $120.80M.
- 2022-06-30: Entity Public Float $125.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $244.40M 10-K · filed 2026-03-30 |
| 2024-06-28 | $477.20M 10-K · filed 2025-03-03 |
| 2023-06-30 | $120.80M 10-K · filed 2024-03-26 |
| 2022-06-30 | $125.00M 10-K · filed 2023-03-06 |
| 2021-06-30 | $750.00M 10-K · filed 2022-03-01 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |